Abbvie Inc Stock Today
| ABBV Stock | USD 190.60 2.37 1.23% |
PerformanceOK
| Odds Of DistressLow
|
AbbVie is selling for under 190.60 as of the 8th of February 2025; that is 1.23 percent decrease since the beginning of the trading day. The stock's lowest day price was 190.44. AbbVie has less than a 13 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Note, on January 7, 2025, Representative Virginia Foxx of US Congress acquired under $15k worth of AbbVie Inc's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 2nd of January 2013 | Category Healthcare | Classification Health Care |
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 1.77 B outstanding shares of which 18.16 M shares are presently shorted by private and institutional investors with about 3.12 trading days to cover. More on AbbVie Inc
Moving against AbbVie Stock
| 0.44 | MNOV | MediciNova Earnings Call This Week | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
AbbVie Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Robert CPA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [AbbVie Inc, AbbVie Inc] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, ARCA Pharmaceutical, SP 500 Index, SP 100 Index, SP 100, Dow Jones Biotechnology, ARCA Institutional, Cannabis, Giant Impact, Macroaxis Index, Health Care, Biotechnology, Drug Manufacturers—General, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal TestingCatholic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAbbVie can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand AbbVie's financial leverage. It provides some insight into what part of AbbVie's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AbbVie Inc (ABBV) is traded on New York Stock Exchange in USA. It is located in 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 and employs 50,000 people. AbbVie is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 341 B. AbbVie Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 1.77 B outstanding shares of which 18.16 M shares are presently shorted by private and institutional investors with about 3.12 trading days to cover.
AbbVie Inc currently holds about 11.88 B in cash with 22.84 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.72.
Check AbbVie Probability Of Bankruptcy
Ownership AllocationAbbVie holds a total of 1.77 Billion outstanding shares. The majority of AbbVie Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AbbVie Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AbbVie. Please pay attention to any change in the institutional holdings of AbbVie Inc as this could imply that something significant has changed or is about to change at the company. On January 7, 2025, Representative Virginia Foxx of US Congress acquired under $15k worth of AbbVie Inc's common stock.
Check AbbVie Ownership Details
AbbVie Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bank Of New York Mellon Corp | 2024-09-30 | 17.1 M | |
| Capital World Investors | 2024-09-30 | 15.5 M | |
| Legal & General Group Plc | 2024-09-30 | 15.2 M | |
| Franklin Resources Inc | 2024-09-30 | 13.9 M | |
| Ameriprise Financial Inc | 2024-09-30 | 13.8 M | |
| Fmr Inc | 2024-09-30 | 13.6 M | |
| Ubs Group Ag Usd | 2024-09-30 | 11.5 M | |
| Ubs Group Ag Usd | 2024-09-30 | 11.5 M | |
| Vanguard Group Inc | 2024-09-30 | 171.6 M | |
| Blackrock Inc | 2024-09-30 | 136 M | |
| Jpmorgan Chase & Co | 2024-09-30 | 104.4 M |
AbbVie Historical Income Statement
AbbVie Stock Against Markets
AbbVie Corporate Directors
| Brett Hart | Independent Director | Profile | |
| Roxanne Austin | Independent Director | Profile | |
| Edward Rapp | Independent Director | Profile | |
| Frederick Waddell | Independent Director | Profile |
Already Invested in AbbVie Inc?
The danger of trading AbbVie Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AbbVie is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AbbVie. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AbbVie Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.